Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer to use Linguamatics Text-Mining Software in New Biotherapeutics and Bioinnovation Center

NEW YORK (GenomeWeb News) - Linguamatics, a provider of natural language processing technology, said today that it has extended an existing collaboration with Pfizer.
Under the terms of the extended agreement, Pfizer will use Linguatmatics' I2E text-mining software within its Biotherapeutics and Bioinnovation Center, a new “entrepreneurial” R&D center that the company created last fall with the goal of advancing translational research via internal development as well as in-licensing and incubating new technologies and research tools.
Financial details of the agreement were not disclosed.
David de Graaf, director of systems biology at Pfizer, said in a statement that the company was previously using I2E “for focused knowledge discovery from large document collections in a variety of R&D applications.”
Under the extended agreement, he said, Pfizer is using the platform “to inform research decisions” within the Biotherapeutics and Bioinnovation Center.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.